Oviva Therapeutics, a Cambrian BioPharma *PipeCo, announces Seed Financing and Exclusive License with Massachusetts General Hospital to Develop Therapeutics to Extend Healthspan in Women
关注订阅预警-> 医药魔方数据库2022-05-19
null
（以上内容由医药魔方AI生成）
资讯来源：美通社
查看原文
阅读 709